RxDoctor Payments Data

Luven Mari Tejero, MD

Psychiatry · Adrian, MINPI 1659421915

Payments from drug & device makers

$2,202in general payments, 2019–2025

Across 149 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$498
  • Otsuka America Pharmaceutical, Inc.$379
  • Teva Pharmaceuticals USA, Inc.$249
  • Alkermes, Inc.$207
  • AbbVie$161
  • Neurocrine Biosciences, Inc.$139
  • plus $570 from 10 others

What the payments were for

  • Food & beverage$2,08995%
  • Education$1145%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,202 in reported general payments places this provider in the 85th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$51,324
Medicare patients
122
Services billed
778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine49$315,946
Abilify MaintenaAripiprazole82$199,529
VraylarCariprazine Hcl81$107,557
Risperdal ConstaRisperidone Microspheres51$51,027
CaplytaLumateperone Tosylate32$50,690
Invega SustennaPaliperidone Palmitate22$46,671
AuvelityDextromethorphan Hbr/Bupropion20$23,068
Clozapine287$22,417
LybalviOlanzapine/Samidorphan Malate13$18,888
TrintellixVortioxetine Hydrobromide28$15,398
VyvanseLisdexamfetamine Dimesylate43$14,979
RexultiBrexpiprazole11$13,391
Fluphenazine Hcl47$9,152
Vilazodone Hcl147$8,671
Quetiapine Fumarate ErQuetiapine Fumarate55$7,692

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$249$315,94649 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$379$212,92193 claims
AbbVieVraylar$161$107,55781 claims
Johnson & JohnsonRisperdal Consta, Invega Sustenna$69$97,69873 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$57$50,69032 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$23$30,37871 claims
Alkermes, Inc.Lybalvi$207$18,88813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Adrian

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →